Here are relevant reports on : pcr-thermocycler-market
-
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029
The global Digital PCR and qPCR market, valued at US$9.4 billion in 2023, stood at US$10.0 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$14.8 billion by the end of the period. Growth in the digital PCR (dPCR) and real-time PCR (qPCR) market can be attributed to factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous advancements in PCR technologies, the role of PCR in biomarker discovery, and increased use of dPCR and qPCR technologies for point of care (POC) diagnostics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), End-user (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030
The global PCR technologies market, valued at US$13.88 billion in 2023, stood at US$14.61 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2030, culminating in a forecasted valuation of US$21.89 billion by the end of the period. The development of novel and innovative products and company initiatives, such as partnerships, product launches, approvals and acquisitions, have supported market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030
The global veterinary reference laboratory market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$6.45 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028
The global blood screening market, valued at US$2.3 billion in 2022, stood at US$2.4 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.4 billion by the end of the period. The need for blood is ever-increasing, forcing the number of blood donations to rise as well throughout the world. Combining this factor along with the growing infectious diseases is the major contributor for the growing blood screening market.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma (Non-Hodgkin, Hodgkin), Technology (PCR, NGS), End User & Region - Global Forecast to 2027
The global hemato oncology testing market growth is primed to transition from $2.9 billion in 2022 to $5.6 billion by 2027, showcasing a strong CAGR of 14.2%. The growth in this market is attributed to the increasing number of the hematologic cancer patients as these patient require the regular monitoring and the diagnostic testing during the treatment.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User and Region - Global Forecasts to 2024
The neurodiagnostics market is projected to reach USD 8.4 billion by 2024, at a CAGR of 7.3%. Some of the prominent players in this market includes GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V. (Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro (Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics (US).
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics) & Region - Global Forecast to 2026
The global influenza diagnostics market growth is primed to transition from $0.8 billion in 2021 to $1.1 billion by 2026, showcasing a strong CAGR of 7.7%. Key factors driving this growth include increasing demand for rapid disease diagnosis, rising influenza prevalence, and advancements in diagnostic technologies.
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostic Market by Technology (Rapid Diagnostic Test, PCR, Microscopy, ELISA, Isothermal Nucleic Acid Amplification), End User (Hospital & Diagnostic Laboratories, Blood Bank, Research Institute/Academics, Home care center) - Global Forecast to 2023
Rising prevalence of malaria in developing countries, increasing demand of molecular based diagnostics test and increasing funding and government support towards developing diagnostic kits are some of the factors driving the growth of the malaria diagnostics market. On the other hand, high expense involved in R&D activities is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Minimal Residual Disease Market by Product (Kits, Instruments), Technology (PCR, NGS), Application (Leukemia, Lymphoma, Multiple Myeloma, Solid Tumors), End User (Hospitals, Diagnostic Labs, Research Institutes), & Region - Global Forecast to 2029
The global minimal residual disease testing market, valued at US$1.27 billion in 2023, stood at US$1.43 billion in 2024 and is projected to advance at a resilient CAGR of 12.2% from 2024 to 2029, culminating in a forecasted valuation of US$2.55 billion by the end of the period. The market is driven by the growing prevalence of cancer globally and increasing funding from international organizations and governments for cancer prevention programs.
- Published: February 2025
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
